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Certain polyhalogenated aromatic hydrocarbons such as polychlorinated biphenyls (PCBs) and
dibenzo-p-dioxins (dioxins, 2,3,7,8-tetrachlorodibenzo-p-dioxin) have been shown to have neurotoxic
effects and to alter thyroid function during critical periods of thyroid hormone-dependent brain
development. This has led to the suggestion that some of the neurotoxic effects of these
compounds could be mediated through the thyroid system. Thyroid hormones are essential for
normal brain development during a critical period beginning in utero and extending through the first
2 years postpartum. They regulate neuronal proliferation, migration, and differentiation in discrete
regions of the brain during definitive time periods. Even transient disruption of this normal pattern
can impair brain development. Thyroid hormones are necessary for normal cytoskeletal assembly
and stability and the cytoskeletal system is essential for migration and neuronal outgrowth. In
addition, they regulate development of cholinergic and dopaminergic systems serving the cerebral
cortex and hippocampus. Animals perinatally exposed to certain environmental organohalogens
such as many of the PCBs and dioxins have abnormal thyroid function and neurologic impairment.
Although there are both species and congener variabilities, most reports show exposure results in
thyroid enlargement and reduced serum T4 levels with normal T3 levels. Initial research
concentrated on studying the direct actions of xenobiotics on the thyroid; however, some of these
compounds bear a structural resemblance to the natural thyroid hormones and have high affinity
with thyroid hormone-binding proteins such as transthyretin. These compounds could act as
agonists or antagonists for receptors of the thyroid/steroid/retinoic acid superfamily. These
structurally similar organohalogens could act at multiple points to alter thyroid hormone action. The
similarity of the neurologic impairment seen in thyroid disorders to that seen following PCB or dioxin
exposure suggests that one mechanism of neurotoxicity of these compounds could involve
interaction with the thyroid system. Key words: brain development, dioxin, organohalogens,
polychlorinated biphenyls, thyroid function. - Environ Health Perspect 108(suppl 3):433-438 (2000).
http.//ehpnetl.niehs.nih.gov/docs/2000/suppl-3/433-438porterfield/abstract.html
Thyroid hormones are essential for normal
brain development in animals and humans
and either excess or deficient hormone levels
produce significant neurologic impairment if
abnormal exposure to environmental chemi-
cals occurs during specific developmental
windows. The relationship between polyhalo-
genated biphenyls and neurologic function is
complex. Prenatal exposure to specific
biphenyls has been associated with abnormal-
ities in neurologic function. Because toxicant
exposure can alter brain thyroid hormone
availability and the effects of toxicant expo-
sure frequently resemble those of prenatal
hypothyroidism (1), there is a need to estab-
lish more definitive relationships between
toxicant exposure and neurologic function.
The complexity of the developing nervous
system makes this a difficult task. Because
many of these toxicants can produce neuro-
toxicity independently of any action on the
thyroid system, it is important that both
those actions mediated independently ofthe
thyroid, perhaps through the aryl hydrocar-
bon (Ah) receptor, and those mediated
through the thyroid system be defined. This
requires further research at the cellular and
molecular levels. These studies are compli-
cated by the fact that transport of either
hormones or the toxicants into brain is
complex and involves multiple pathways with
multiple potential regulatory points.
Development ofthe Thyroid
The thyroid, pituitary, and hypothalamus
begin development early in gestation (2).
Thyroid hormone synthesis begins at 10-12
weeks gestation (3), and serum thyroid hor-
mone levels rise progressively throughout the
remainder ofgestation (4). Thehypothalamic-
pituitary-thyroid axis is functional by the lat-
ter halfofgestation, and maturation contin-
ues until approximately 2 months postpartum
in humans (5). Ligand-bound thyroid hor-
mone receptors are seen by 10 weeks gestation
in humans (6).
The Role ofThyroid Hormones
in Nervous System
Development
Thyroid hormones are important regulators
of brain development during the fetal and
neonatal periods. They control neuronal and
glial proliferation in definitive brain regions
and regulate neuronal migration and differ-
entiation. Differentiation includes the
development of neuronal connectivity and
myelination. Because neurologic development
occurs in discrete developmental windows,
the role ofthyroid hormones in orchestrating
the timing ofspecific developmental events
and signals is crucial and even transient disor-
ders in thyroid hormone availability can have
profound effects on brain development.
Endemic Cretinism
The most severe neurologic impairment
resulting from a thyroid deficiency is in
endemic cretinism caused by iodine defi-
ciency. In fact, iodine deficiency represents
the single most preventable cause ofneuro-
logic impairment and cerebral palsy in the
world today (7,8). These individuals suffer
from hypothyroidism that begins at concep-
tion because the dietary iodine deficiency pre-
vents synthesis of normal levels of thyroid
hormones. It is more severe than that seen in
congenital hypothyroidism because the defi-
ciency occurs much earlier in development
and results in decreased brain thyroid hor-
mone exposure both before and after the time
the fetal thyroid begins functioning.
Problems with endemic cretins include men-
tal retardation that can be profound, spastic
dysplasia, and problems with gross and fine
motor control resulting from damage to both
the pyramidal and the extrapyramidal sys-
tems. These problems include disturbances of
gait, and in the more extreme forms, the indi-
viduals cannot walk or stand (8-10). Ifpost-
natal hypothyroidism is present, there is
growth retardation and delayed or absent sex-
ual maturation (3). Damage occurs both to
structures such as the corticospinal system
that develop relatively early in the fetus and
structures such as the cerebellum that develop
predominantly in the late fetal and early
neonatal period. The damage is inversely
related to maternal serum thyroxine (T4) lev-
els but not to triiodothyronine (T3) levels
(3,8,11). Delong (12) suggests that the neu-
rologic damage occurs primarily in thesecond
trimester, which is an important period for
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formation of the cerebral cortex, the
extrapyramidal system, and the cochlea, areas
damaged in endemic cretins. Maternal T3 lev-
els are often normal and the mother therefore
may not show any overt symptoms of
hypothyroidism. Early development of the
auditory system appears to be dependent
upon thyroid hormones (13). The greater
impairment characterized by endemic cre-
tinism relative to congenital hypothyroidism
is thought to result from the longer period of
exposure of the developing brain to hypo-
thyroidism in endemic cretinism (3,7,8).
Congenital Hypothyroidism
Untreated congenital hypothyroidism (sporadic
cretinism) produces neurologic deficits hav-
ing predominantly postnatal origins.
Although mental retardation can occur, it
typically is not as severe as that seen in
neurologic cretinism. Untreated infants with
severe congenital hypothyroidism can lose
3-5 IQpoints per month ifuntreated during
the first 6-12 months oflife (14). Ifthe chil-
dren are treated with thyroid hormones soon
after birth, the more severe effects ofthyroid
deficiency are alleviated. However, these chil-
dren are still at risk for mild learning disabili-
ties. They may show subtle language,
neuromotor, and cognitive impairment (15).
They are more likely to show attention
deficit hyperactivity disorder (ADHD), have
problems with speech and interpretation of
the spoken word, have poorer fine motor
coordination, and have problems with spatial
perception (16). The severity ofthese effects
is correlated with the retardation of bone
ossification seen at birth. This would suggest
that the damage is correlated with the mild
hypothyroidism they experience in utero.
Rovet and Ehrlich (17) have proposed that
the sensitive periods for thyroid hormones
vary for verbal and nonverbal skills. The crit-
ical period for verbal and memory skills
appears to be in the first 2 months postpar-
tum, whereas for visuospatial or visuomotor
skills it is prenatal.
Thyroid hormone deficiency impairs
learning and memory, which depend on the
structural integrity of the hippocampus.
Maturation and synaptic development ofthe
pyramidal cells ofthe hippocampus are partic-
ularly sensitive to thyroid hormone deficiency
during fetal/perinatal development (18). Early
in fetal development (rats), thyroid hormone
deficiency decreases radial glial cell maturation
and therefore impairs cellular migration (19),
which can lead to irreversible changes in the
neuronal population and connectivity in this
region. Animals with experimentally induced
congenital hypothyroidism show delayed and
decreased axonal and dendritic arborization
in the cerebral cortex, a decrease in nerve
terminals, delayed myelination, abnormal
cochlear development, and impaired middle
earossidedevelopment (3).
Resistance toThyroid Hormones
Resistance to thyroid hormones (RTH) is a
genetic disorder typically resulting from a
point mutation ofthe gene producing the
thyroid hormone beta receptor (TRf). The
presence ofthe mutant gene can exert a dom-
inant negative effect on thyroid hormone
receptor alpha (TRa)-directed transactivation
(20). Peoplewith RTH commonlyshow neu-
rologic deficiencies that include a higher inci-
dence ofauditory deficiencies and a relatively
high incidence ofADHD (21). This impair-
ment has been confirmed through behavioral
testing and magnetic resonance imaging of
the sylvian fissure show discrete structural
abnormalities in the cerebral cortex (22). The
latter damage would most likely result from a
deficient action ofthyroid hormones in utero
and the earlypostnatal period.
DatafomAnimals
Ifpregnant rats are treated with the goitrogen
propylthiouracil (PTU) early in pregnancy, it
delays neuronal proliferation in both the
motor and the mesencephalic nuclei ofthe
trigeminal nerve. These neurons normally
form relatively early in gestation at a period
that would correspond to the first halfofges-
tation in humans (23). Eventually these neu-
rons are produced, but the timing ofneuronal
birth, migration, and synaptogenesis is finely
tuned and if neurons are not formed at the
appropriate time, they may never reach the
right cell layer ofthe brain and form normal
neuronal synapses. Disorganization ofthe cel-
lular layers ofthe cerebellar cortex has been
shown to occur in postnatal hypothyroidism
in rats (24). The cellular changes reported by
Narayanan and Narayanan (23) are reflected
* Progeny ofcontrol
in behavioral effects. The trigeminal nerve is
important for suckling and the PTU-treated
pups had difficulty suckling. Rat fetuses
exposed to slightly lower brain thyroid hor-
mone levels in utero have problems with
learning and memory and are hyperactive as
adults, even though thyroid hormone levels
are normal as adults (25) (Figure 1).
Neurite Outgrowth and
Cellular Migration
Thyroid hormone deficiency during a critical
developmental period can impair cellular
migration and development ofneuronal net-
works. Neuronal outgrowth and cellular
migration are dependent on normal micro-
tubule synthesis and assembly and these latter
processes are regulated by thyroid hormones
(26). During cerebral development, post-
mitotic neurons forming near the ventricular
surface must migrate long distances to reach
their final destination in the cortical plate
where they form a highly organized 6-layer
cortical structure. Appropriate timing ofthis
migration is essential ifnormal connectivity is
to be established. This migration depends not
only upon specialized cells such as the radial
glial cells that form a scaffolding system but
also on specific adhesion molecules in the
extracellular matrix that are associated with
the focal contacts linking migrating neurons
with radial glial fibers (27). These neurons
migrate along radial glial fibers, and following
neuronal migration, the radial glial cells often
degenerate or become astrocytes (28).
Migration also depends on adhesive interac-
tions involving extracellular matrix proteins
such as laminin and the cell-surface receptor
integrin. Laminin is synthesized by astrocytes
and bound to the astrocyte surface by the
transmembrane receptors integrin and the
integrins are held in place by the intracellular
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Figure 1. Errors in a Lashley Maze by progeny of hypothyroid (Tx) rats versus progeny of control rats. The progeny of
Tx dams are exposed to low levels of thyroid hormones during most of fetal development. While the control progeny
learn the maze over 10 trials (trials 2-10 < 1; 4-10 < 2; 8-10 < 3; p = 0.05), the progeny of Tx dams never learn the
mazeduring that period. Data from Hendrich et al. (25).
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astrocyte microfilament network. These
macromolecular complexes are called focal
contacts and provide directional clues for
elongating neurons. T4 regulates focal contact
formation by astrocytes by promoting actin
polymerization (26,29). T4 but not T3 regu-
lates the appearance and regional distribution
oflaminin in the developing rat cerebellum
(30), as well as the microfilament network
associated with integrins, and T4 but not T3
directly alters neurite outgrowth and neuronal
migration on laminin in cerebellar explants.
Disorders ofneuronal migration are consid-
ered to be major causes ofboth gross and sub-
tle brain abnormalities (28). Hypothyroidism
during fetal and neonatal development results
in delayed neuronal differentiation and
decreased neuronal connectivity (26).
Synaptogenesis and
Myelinogenesis
Thyroid hormones regulate development of
certain cholinergic and dopaminergic neuro-
transmitter systems (31,32). The cholinergic
fibers projecting from the hippocampus to
the basal forebrain, including the striatum,
are particularly sensitive to thyroid hormone
deficiency (32). These cholinergic fibers are
important in memory and learning, and a
well-functioning cholinergic system is a pre-
requisite for performance on spatial learning
tasks in rodents (33). This cholinergic system
has also been proposed as a site for damage in
ADHD). These brain regions (hippocampus,
basal forebrain) have particularly high levels
ofthyroid hormone receptors during develop-
ment and are sites where thyroid hormones
regulate nerve growth factor (NGF) produc-
tion (34-36). Thyroid hormones and NGF
cooperate in the development of specific
cholinergic systems in the central nervous sys-
tem (37), and thyroid hormones could regu-
late neurotransmitter development through
their action on NGF production in these spe-
cific regions. Hypothyroidism decreases
choline acetyltransferase (ChAT) quantities in
brain regions innervated by these neurons
(32) because thyroid hormones serve as posi-
tive regulatory factors for the ChAT gene
(38). This drop in ChAT quantity is pre-
ceded by a drop in nerve growth factor recep-
tor (NGFR) levels, suggesting that thyroid
hormone actions could be mediated by its
action on NGFRproduction (32). The devel-
opment of both dopaminergic and choliner-
gic systems is delayed in hypothyroidism
(39). In addition, T3 regulates expression of
the neuron-specific gene for synapsin I, an
important protein regulating neurotransmit-
ter release and synaptic plasticity (40).
Gliogenesis is delayed as is myelination in
hypothyroidism (3,26). In this case, the
impairment represents a developmental delay
rather than a block.
Sources of Brain Thyroid
Hormones
Thyroid hormone synthesis does not begin
until 10-12 weeks of gestation in humans
and 17 days ofgestation in the rat (3). While
many important aspects ofbrain development
occur either before the time offetal thyroid
hormone synthesis or at least before synthesis
ofhigh levels offetal hormone, thyroid hor-
mones are available from the mother during
early gestation (3,7). Thyroid hormones are
present in small quantities in rat and human
fetal tissue at the earliest ages that it is feasible
to measure tissue hormone levels (3,41).
These low levels of maternal thyroid hor-
mones might be important for developmental
events such as cerebral and brain-stem neuro-
genesis that occur relatively early in develop-
ment. The importance ofmaternal thyroid
hormones in fetal brain development is seen
in the recently published data of Haddow
et al. (42), showing that maternal thyroid
deficiency during pregnancy can impair sub-
sequent neuropsychologic development in
children. Later in gestation, both maternal
and fetal thyroid hormones are important for
fetal brain development. At the time ofbirth,
as much as 17.5% ofthe thyroid hormones
found in the newborn are ofmaternal origin
in rats (43) and maternal thyroid hormones
can produce neonatal thyroid hormone levels
approaching the low normal level in congeni-
tally hypothyroid children with a complete
inability to synthesize thyroglobulin and
therefore thyroid hormones (44).
How Do Thyroid Hormones
Reach the Brain?
Thyroid hormones enter the brain through
two routes. The predominant route is via the
blood-brain barrier involving direct transport
through the capillary endothelium and into
the brain cells. Hormone transport via this
route depends on the serum hormone levels
(influenced by serum protein-binding rela-
tionships), the transport systems through the
endothelium, and the transport systems into
the brain cells. The second and less significant
route is via the choroid plexus-cerebrospinal
fluid (CSF). The thyroid hormone-binding
protein transthyretin (TTR) binds T4 but not
T3. It is produced by the choroid plexus and
secreted into the CSF. The TTR then binds
to T4 that enters CSF through the choroid
plexus and may play an important role in T4
transport to the brain cells. Hydroxylated
PCBs have a stronger binding affinity for
TTR than even T4 and therefore the presence
of these PCBs could compete with T4 for
transport on TTR. In addition, the transport
systems for thyroid hormones across cell
membranes involve saturable, stereospecific
carrier-mediated transport systems (45,46). It
is possible that these structurally similar
toxicants could also compete with thyroid
hormones for transport across cell mem-
branes. Although the T3 has the higher affin-
ity for the thyroid hormone nuclear receptor,
T4 is the predominant form transported into
brain. Most ofthe brain intracellular T3 pool
is derived from local deiodination ofT4 to T3
by the enzyme iodothyronine 5'-deiodinase
(type II).
Development ofThyroid
Hormone Receptors
Thyroid hormone receptor binding is present
in both the fetal rat brain by 13 days ofgesta-
tion and the fetal human brain by 10 weeks
ofgestation (6,47). Fetal thyroid hormone
secretion begins at 17 days postconception in
rats and 8-10 weeks in humans (3,47). The
fetal rat brain contains predominantly TRal
and TRa2. While small quantities ofTRf1
are expressed early in gestation in specific
regions such as the fetal rat otic vesicles (the
precursor to the cochlea) (13), most TR31
expression occurs late in gestation and the rise
in expression corresponds with the rise in
fetal/neonatal T4 secretion (47). The highest
concentrations ofT3-binding sites in the
adult brain are found in the hippocampus,
amygdala, and the cerebral cortex, regions of
the brain known to be particularly sensitive to
thyroid hormone action (31).
Thyroid Hormone Action
Thyroid hormone receptors are transcription
factors requiring interactions with multiple
proteins to regulate gene expression. There
are at least three functional thyroid hormone
receptors formed from two gene transcripts,
TRa1, TR,B1, and TR,2. The TRa2 isotype
does not bind ligand. However, the presence
of the TRa2 isotype is thought to inhibit
gene regulation mediated through the other
isotypes (20). Recent data from TRa and
TR, null transgenic mice suggest that func-
tions regulated by one receptor type can at
least partially be compensated for by the
other receptor type (48).
Work is currentlyunderwaycharacterizing
the respective roles ofthe a and P receptor
types. Studies ofthis nature are complicated
by the fact that mutant forms ofthe gene can
exert a dominant negative effect on functions
of the other gene, thereby magnifying the
severity ofthe deficiency (20). Thyroid hor-
mone receptors, unlike steroid receptors, do
not require ligand to bind to the receptor. In
fact, the unliganded alpha receptor present in
early fetal development may be an important
inhibitor oftranscription ofcertain thyroid
hormone-regulated genes. Thyroid hormone
receptors dimerize, and they can either form a
homodimer with another thyroid hormone
receptor or they can form a heterodimer with
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000 435S.P. PORTERFIELD
proteins such as the retinoic acid receptor or
retinoid X receptor. The ability ofthyroid
hormones to turn on or turn offa specific
gene is controlled by various proteins acting
as corepressors or coactivators. The thyroid
hormone receptor is a member ofthe thyroid
hormone-retinoic acid-steroid hormone
receptor superfamily and as such shows con-
siderable homologywith the retinoic acid and
the steroid hormone receptors. Excess retinoic
acid can act as aneurologic teratogen.
Thyroid hormones regulate gene expression
ofa limited number ofgenes. Genes regu-
lated by thyroid hormones in brain include
purkinje cell protein, myelin basic protein,
nerve growth factor 1-A, NADH dehydroge-
nase subunit 3, and rat cortex clone 3 (RC3)
(neurogranin or calbindin) (37,49-52). The
gene for the phosphocreatine kinase C sub-
strate RC3 is the onlygene shown to be regu-
lated by thyroid hormones in the adult, as
well as the fetal brain (47). These other genes
are developmentally regulated in brain.
Although thyroid hormones have extensive
effects on brain development both in vivoand
in vitro, only a fewgenes appear to bedirectly
regulated by thyroid hormones. This dispar-
ity could result from multiple potential fac-
tors. It is possible that there are intervening
factors regulating thyroid hormone-con-
trolled brain development. These could
include the potential impact ofother hor-
mones, growth factors, or transcription fac-
tors. Thyroid hormones are thought by many
to be capable ofhaving both genomic and
nongenomic actions. Perhaps some of the
actions ofthyroid hormones on brain devel-
opment involve nongenomic actions. Farwell
and Leonard (53) have shown that thyroid
hormone regulation ofglial type II iodothy-
ronine 5'-deiodinase, the enzyme converting
T4 to T3, results from adirect action ofT4 on
cellular actin filaments.
PCBs as Hormonally Active
Compounds
Certain PCBs and chlorinated dibenzo-p-
dioxin congeners are structurally similar to
the active thyroid hormones (54). These
structural similarities could theoretically lead
to endocrine disruption ifthe compounds act
as agonists or antagonists to the naturally
occurring hormone. These compounds
include many ofthe 209 congeners ofPCBs
and many ofthe 75 possible congeners ofthe
dioxins. Maier et al. (55) have demonstrated
that the ortho-substituted PCB congeners are
more neuroactive than the non-ortho-
substituted congeners and those compounds
with lateral halogen substitution exert many
oftheir biologic actions byactingthrough the
Ah receptor. In addition, there are multiple
possible mechanisms ofaction ofthese com-
pounds on the thyroid system. These
compounds are structurally similar to thyroid
hormones and therefore have the potential of
binding to proteins that characteristically
bind thyroid hormones such as the serum-
binding proteins or the thyroid hormone
receptor. Laterally substituted chlorinated
aromatic compounds such as the meta and
para PCBs, particularly when hydroxylated,
are ideally suited to serve as binding ligands
for T4-binding proteins (54,56). Because
environmental persistence is correlated with
lateral substitution, many ofthe congeners
accumulating in the environment are likely to
impact the thyroidal system (55).
Actions ofOrganohalogens
on theThyroid
These organohalogens could have direct toxic
effects on the thyroid, as suggested by the
observed histologic changes reported in the
glands ofanimals exposed to certain PCB and
2,3,7,8-TCDDcongeners that are suggestive
of the histologic changes occurring in
Hashimoto's thyroiditis in humans (57).
These histologic changes are often associated
with normal orhighserum thyroid-stimulating
hormone (TSH) levels with low serum T4
levels (58), suggesting aprimary thyroidal dis-
order. Morse et al., (59) have shown that
maternal exposure to Aroclor 1254 signifi-
cantly decreases fetal and neonatal plasma T4
levels in a dose-dependent manner and
decreases forebrain and cerebellar T4 concen-
trations in fetal rats on day 20. The predomi-
nant metabolite accumulating in fetal plasma
and forebrain was the hydroxylated congener
2,3,3',4',5-pentachloro-4-biphenylol. The
hydroxylated congeners ofPCBs have a high
affinity for TTR (1,56,60-62). Cheek et al.
(62) have shown that halfthe hydroxylated
PCBs they tested had higher affinities than
did T4 for TTR. Only two ofthe hydroxy-
lated PCBs bound thyroxine-binding globu-
lin, the major transport protein in humans.
Only the hydroxylated PCBs inhibited T3
binding to TR3; binding affinity was less
than 1/10,000 that ofT4 (65). The lower
serum T4 levels in PCB-exposed rats could
probably result in part from increased metab-
olism ofthyroid hormones. PCB exposure of
perinatal rats (61) and adult rats (63)
increases biliary excretion ofT4 by inducing
the enzyme T4-uridine diphosphoglucuronyl-
transferase, thereby increasing hepatic T4
glucuronidation (1).
NeurologicEffictsofOrganohalogens
In many species, including humans, perina-
tal exposure to certain PCB and dioxin con-
geners can produce neurologic impairment.
Children in Taiwan accidentally exposed
prenatally to high levels of PCBs (Yu-
Cheng, "oil disease") tended to have
impaired cognitive development, with these
children at 4-5 years of age scoring an
average of approximately 5 points lower
than unexposed children on the Stanford-
Binet test (64). Because most of these chil-
dren were not breast fed, their predominant
exposure occurred in utero. Jacobson and
Jacobson (65) have followed the children of
a cohort ofwomen who had eaten the equiv-
alent of at least 11.8 kg of PCB-contami-
nated Lake Michigan fish during the 6-year
period prior to giving birth. Prenatal expo-
sure of these children to PCBs was associ-
ated with lower full-scale and verbal IQ
scores, with the strongest effects seen on
short-term and long-term memory and
focused and sustained attention. Verbal
skills and reading comprehension were
impaired. Even though more PCB exposure
occurs during lactation than in utero, the
deficits were associated with prenatal not
lactational exposure, suggesting the greatest
vulnerability to PCB toxicity ofthe develop-
ingbrain occurs in utero.
Rodents exposed in utero to PCBs have
impaired active avoidance acquisition, hyper-
activity, and impaired discrimination learn-
ing (1,66). Hyperactivity in mice following
fetal exposure to the congener 3,3',4,4'-
tetrachlorobiphenyl has been attributed to
decreased levels ofdopamine and dopamine
receptor in strial synapses (67). Schantz and
Bowman (68) and Schantz et al. (69) have
shown that monkeys perinatally exposed to
PCBs have problems with learning and
memory (70). Rat pups exposed to PCBs
show delayed development ofnegative geot-
axis, auditory startle, and righting reflexes
(66), developmental problems were also
noted in congenitally hypothyroid rats (71).
Mice pups exposed to PCBs in utero show
hyperactivity, and the increased activity is
correlated with decreases in dopamine and
dopamine-binding sites in the caudate nuclei
as well as long-lasting changes in the devel-
opment ofstriatal synapses (66). The stria-
tum is highly sensitive to the actions of
thyroid hormones (72).
The developing auditory system is known
to be sensitive to thyroid hormones, and
hearing disorders including deafmutism are
common in endemic cretinism, with less
severe auditorydisturbances occurring in con-
genital hypothyroidism (73). In addition, an
increased incidence ofsensorineural deafness
has been noted in RTH (74). Bradley et al.
(13) have shown acorrelation between neuro-
logic deafness and expression ofTr,1 and
TrP2 in the region ofthe embryonic ear (ven-
tral otocyst) giving rise to the cochlea. When
Long-Evans rats are given Aroclor 1254 dur-
ing gestation through lactation, the pups
(through day 30 postpartum) had low serum
T4 levels and permanent auditory deficits that
most likely resulted from impaired cochlear
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development (75). In turn, rats given the
goitrogen PTU during this same period had
similar auditory deficits, the severity ofwhich
correlates with the decreased thyroid
hormone secretion (76).
PCBs and Neurotransmitters
Alterations in neurotransmitter levels in
discrete brain regions have been associated
with behavioral problems. Both thyroid hor-
mones and certain organohalogens such as
some ofthe PCB congeners and dioxins alter
biogenicamines in regions ofthebrain such as
the basal forebrain and hippocampus that are
associated with learning and memory. Rat
pups exposed in utero to ortho-substituted but
not coplanar PCB congeners have lower-than-
normal dopamine levels in the basal forebrain
in a manner analogous to what occurs in
hypothyroidism (1,77). Ratpups eitherprena-
tally or lactationally exposed to PCBs have
low ChAT activity in the hippocampus and
basal forebrain (78). The results are the same
as those seen in neonatally hypothyroid rats.
Because PCB exposure lowered serum T4 lev-
els, Juarez et al. (78) treated some ofthe pups
with T4 or T3 and found that T4, but not T3,
returned ChAT activity almost to control lev-
els, thereby suggesting that PCB-induced
ChAT suppression could be mediated
through thethyroidal system.
Summary
Polychlorinated biphenyls and dioxins exert
their neurotoxic effects through multiple
mechanisms. The classical mechanism is
through interactions with the Ah receptor. In
addition, manyofthe congeners ofPCBs and
dioxins alter thyroid function. Because thy-
roid hormones are essential for normal brain
development, it is possible that the xeno-
biotics could produce neurotoxicity indirectly
by altering thyroid-regulated brain develop-
ment. Many of the neurotoxic effects of
organohalogens reported in humans and
experimental animals resemble those seen in
fetal/neonatal hypothyroidism. Because brain
development occurs in very discretewindows,
transient exposure ofthe developing brain to
either abnormal thyroid hormone levels or to
excessive organohalogens could potentially
have lasting neurologic effects. Potential
mechanisms ofneurotoxicity that could be
induced by organohalogens acting through
the thyroidal system include the following: a)
The toxicants could alter thyroid hormone
synthesis and secretion, either by acting
directly on the thyroid gland or through act-
ing on the pituitary or hypothalamic control
ofTSH secretion. b) The toxicants could
compete with thyroid hormone for serum-
binding proteins, thereby potentially impair-
ing tissue hormone delivery. c) The toxicants
could compete with thyroid hormones for
membrane carrier systems and therefore
inhibit tissue uptake ofthe hormones. d) The
toxicants could be either agonists or antago-
nists for thyroid hormone receptor binding.
e) The toxicants could alter production of
proteins such as coactivators or corepressors
that regulate transcription of thyroid
hormone-regulated genes. This field remains
afertile areafor further investigation.
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